目的 探討邁之靈片聯(lián)合卵磷脂絡(luò)合碘片治療中心性漿液性脈絡(luò)膜視網(wǎng)膜病變的臨床療效。方法 選取2013年1月-2016年1月在咸陽市第一人民醫(yī)院接受治療的中心性漿液性脈絡(luò)膜視網(wǎng)膜病變患者78例為研究對(duì)象，按照治療方法的差別分成對(duì)照組和治療組，每組各39例。對(duì)照組口服卵磷脂絡(luò)合碘片，1片/次，3次/d。治療組在對(duì)照組基礎(chǔ)上口服邁之靈片，2片/次，3次/d。兩組患者均治療2個(gè)月。觀察兩組的臨床療效，比較兩組患者的視力情況。結(jié)果 治療后，對(duì)照組和治療組的總有效率分別為79.49%、94.87%，兩組比較差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。治療后，兩組患者的視力情況均明顯提高，同組治療前后差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；且治療組這些觀察指標(biāo)的改善程度明顯優(yōu)于對(duì)照組，兩組比較差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 邁之靈片聯(lián)合卵磷脂絡(luò)合碘片治療中心性漿液性脈絡(luò)膜視網(wǎng)膜病變具有較好的臨床療效，能改善視力，具有一定的臨床推廣應(yīng)用價(jià)值。

Objective To investigate the clinical effect of Maizhiling Tablets combined with Iodized Lecithin Tablets in treatment of central serous chorioretinopathy. Methods Patients (78 cases) with central serous chorioretinopathy in the First People's Hospital of Xianyang City from January 2013 to January 2016 were enrolled in this study. According to the difference treatment plan, patients were divided into the control and treatment groups, and each group had 39 cases. Patients in the control group were po administered with Iodized Lecithin Tablets, 1 tablet/time, three times daily. Patients in the treatment group were po administered with Maizhiling Tablets on the basis of the control group, 2 tablets/time, twice daily. After treatment, the clinical efficacies were evaluated, and the visual acuity in two groups was compared. Results After treatment, the clinical efficacies in the control and treatment groups were 79.49% and 94.87%, respectively, and there was difference between two groups (P<0.05). After treatment, the visual acuity in two groups was significantly increased, and the difference was statistically significant in the same group (P<0.05). And the observational indexes in the treatment group were significantly better than those in the control group, with significant difference between two groups (P<0.05). Conclusion Maizhiling Tablets combined with Iodized Lecithin Tablets has clinical curative effect in treatment of central serous chorioretinopathy, and can improve visual acuity, which has a certain clinical application value.